US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

US IPOs and Secondary Offerings

Veradermics, Inc. (MANE):Aesthetic & Dermatology Biotech Sets Terms Seeking up to $

Veradermics, Inc. (MANE): Wellington Anchors Dermatology Biotech but Caution Needed Around Subsector

Veradermics, Inc. (MANE): Dermatology Biotech Blasts Off, Eli Lilly and Wellington Anchor Hot IPO

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>Veradermics filed for an initial public offering on January 9, targeting a market debut late January or early February.</li>
<li>Developing VDPHL01, an oral, non-hormonal, extended-release minoxidil therapy for pattern hair loss in men and women.</li>
<li>Raised $263M from top life sciences investors; led by dermatologists and industry veterans with extensive clinical development experience.</li>
</ul>


Veradermics filed for an initial public offering on January 9, targeting a market debut late January or early February.
Developing VDPHL01, an oral, non-hormonal, extended-release minoxidil therapy for pattern hair loss in men and women.
Raised $263M from top life sciences investors; led by dermatologists and industry veterans with extensive clinical development experience.


베라더믹스(Veradermics, Inc., MANE): 미용 및 피부과 바이오테크 기업의 IPO招股書(기업공개招股書, 투자설명서) 살펴보기

VeraDermics

베라더믹스(Veradermics, Inc., MANE): 미용 및 피부과 바이오테크 기업의 IPO招股書(기업공개招股書, 투자설명서) 살펴보기